Online ISSN: 1949-2553
www.oncotarget.com
About Oncotarget
Our mission is to make scientific results rapidly and widely available. We seek to maximize the impact of research via insightful review, to enable exceptional discoveries to be shared quickly, to eliminate the border between specialties, to link different fields of biomedical science, and to foster application of basic and clinical science to fight disease.

LEARN MORE ABOUT ONCOTARGET

Behind the Study: Genomic, Neoantigen Evolution in Head, Neck Cancer

Oncotarget

January 10, 2022
Drs. Brian Van Tine and Charles Schutt discuss their 2021 research paper, "Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma." continue reading »

Open-Access Oncotarget Shifts to Continuous Publishing

Oncotarget

January 6, 2022
As of 2022, the peer-reviewed and open-access journal Oncotarget has shifted to continuous publishing. continue reading »

Can Purified Cholera Stop Obesity?

Oncotarget

December 30, 2021
In this 2019 study, researchers investigated the effects of purified elements of cholera toxin in age-associated weight gain. continue reading »

Behind the Study: Cholera Toxin and Age-associated Obesity

Oncotarget

December 27, 2021
Dr. Susan Erdman from Massachusetts Institute of Technology (MIT) discusses the 2019 research paper she co-authored, entitled, "Consuming cholera toxin counteracts age-associated obesity." continue reading »

New Study: Biomarkers Linked to the Progression of Endometrial Cancer

Oncotarget

December 22, 2021
Researchers identified differentially regulated signaling pathways and genes related to endometrial cancer (EC) disease progression. continue reading »